384 related articles for article (PubMed ID: 26097867)
1. AID/APOBEC deaminases and cancer.
Rebhandl S; Huemer M; Greil R; Geisberger R
Oncoscience; 2015; 2(4):320-33. PubMed ID: 26097867
[TBL] [Abstract][Full Text] [Related]
2. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis.
Taylor BJ; Nik-Zainal S; Wu YL; Stebbings LA; Raine K; Campbell PJ; Rada C; Stratton MR; Neuberger MS
Elife; 2013 Apr; 2():e00534. PubMed ID: 23599896
[TBL] [Abstract][Full Text] [Related]
3. Evolutionary effects of the AID/APOBEC family of mutagenic enzymes on human gamma-herpesviruses.
Martinez T; Shapiro M; Bhaduri-McIntosh S; MacCarthy T
Virus Evol; 2019 Jan; 5(1):vey040. PubMed ID: 30792902
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
[TBL] [Abstract][Full Text] [Related]
6. Somatic hypermutation in immunity and cancer: Critical analysis of strand-biased and codon-context mutation signatures.
Steele EJ
DNA Repair (Amst); 2016 Sep; 45():1-24. PubMed ID: 27449479
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types.
Jakobsdottir GM; Brewer DS; Cooper C; Green C; Wedge DC
BMC Biol; 2022 May; 20(1):117. PubMed ID: 35597990
[TBL] [Abstract][Full Text] [Related]
8. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
[TBL] [Abstract][Full Text] [Related]
9. APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.
Swanton C; McGranahan N; Starrett GJ; Harris RS
Cancer Discov; 2015 Jul; 5(7):704-12. PubMed ID: 26091828
[TBL] [Abstract][Full Text] [Related]
10. AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature.
Pettersen HS; Galashevskaya A; Doseth B; Sousa MM; Sarno A; Visnes T; Aas PA; Liabakk NB; Slupphaug G; Sætrom P; Kavli B; Krokan HE
DNA Repair (Amst); 2015 Jan; 25():60-71. PubMed ID: 25486549
[TBL] [Abstract][Full Text] [Related]
11. Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA.
Bergstrom EN; Luebeck J; Petljak M; Khandekar A; Barnes M; Zhang T; Steele CD; Pillay N; Landi MT; Bafna V; Mischel PS; Harris RS; Alexandrov LB
Nature; 2022 Feb; 602(7897):510-517. PubMed ID: 35140399
[TBL] [Abstract][Full Text] [Related]
12. Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis.
Shilova ON; Tsyba DL; Shilov ES
Mol Biol; 2022; 56(1):46-58. PubMed ID: 35194245
[TBL] [Abstract][Full Text] [Related]
13. AID and APOBEC deaminases: balancing DNA damage in epigenetics and immunity.
Franchini DM; Petersen-Mahrt SK
Epigenomics; 2014; 6(4):427-43. PubMed ID: 25333851
[TBL] [Abstract][Full Text] [Related]
14. Elevated APOBEC mutational signatures implicate chronic injury in etiology of an aggressive head-and-neck squamous cell carcinoma: a case report.
Patel J; den Breems NY; Tuluc M; Johnson J; Curry JM; South AP; Cho RJ
J Med Case Rep; 2021 Apr; 15(1):252. PubMed ID: 33926553
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.
Koito A; Ikeda T
Front Microbiol; 2013; 4():28. PubMed ID: 23431045
[TBL] [Abstract][Full Text] [Related]
16. Generation of Genomic Alteration from Cytidine Deamination.
Liu X; Meng FL
Adv Exp Med Biol; 2018; 1044():49-64. PubMed ID: 29956291
[TBL] [Abstract][Full Text] [Related]
17. Disruption of Transcriptional Coactivator Sub1 Leads to Genome-Wide Re-distribution of Clustered Mutations Induced by APOBEC in Active Yeast Genes.
Lada AG; Kliver SF; Dhar A; Polev DE; Masharsky AE; Rogozin IB; Pavlov YI
PLoS Genet; 2015 May; 11(5):e1005217. PubMed ID: 25941824
[TBL] [Abstract][Full Text] [Related]
18. The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.
Granadillo Rodríguez M; Flath B; Chelico L
Open Biol; 2020 Dec; 10(12):200188. PubMed ID: 33292100
[TBL] [Abstract][Full Text] [Related]
19. APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer.
Shi MJ; Meng XY; Lamy P; Banday AR; Yang J; Moreno-Vega A; Chen CL; Dyrskjøt L; Bernard-Pierrot I; Prokunina-Olsson L; Radvanyi F
Eur Urol; 2019 Jul; 76(1):9-13. PubMed ID: 30975452
[TBL] [Abstract][Full Text] [Related]
20. DNA deamination in immunity: AID in the context of its APOBEC relatives.
Conticello SG; Langlois MA; Yang Z; Neuberger MS
Adv Immunol; 2007; 94():37-73. PubMed ID: 17560271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
